Longevity Health Holdings, Inc. Common Stock
XAGE
XAGE was delisted on the 11th of September, 2025.
35 hedge funds and large institutions have $135M invested in Longevity Health Holdings, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 13 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
2% more capital invested
Capital invested by funds: $132M → $135M (+$3.11M)
0.01% less ownership
Funds ownership: 2.73% → 2.72% (-0.01%)
13% less funds holding
Funds holding: 40 → 35 (-5)
38% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
+$7.07M |
| 2 |
MC
Meteora Capital
Boca Raton,
Florida
|
+$6.31M |
| 3 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
+$5.8M |
| 4 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$5.24M |
| 5 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
+$2.55M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
-$15.1M |
| 2 |
AC
Antara Capital
New York
|
-$7.97M |
| 3 |
JP Morgan Chase
New York
|
-$3.02M |
| 4 |
ETH
Exos TFP Holdings
New York
|
-$2.97M |
| 5 |
OCM
Oaktree Capital Management
Los Angeles,
California
|
-$2.03M |
XAGE Hedge Fund Activity: Q2 2023 in Review
35 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Longevity Health Holdings, Inc. Common Stock (XAGE) for Q2 2023, worth a combined $135M — up 2.4% from $132M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of XAGE and 8 opened new positions — a net loss of 5 holders — while 4 trimmed existing stakes and 6 added.
The largest buyer was Aristeia Capital, opening a new position worth an estimated $7.07M. The largest seller was Balyasny Asset Management, exiting entirely with an estimated $15.1M sold.
- 35 institutional investors held Longevity Health Holdings, Inc. Common Stock (XAGE) as of Q2 2023, down from 40 in Q1 2023.
- Funds reported $135M of Longevity Health Holdings, Inc. Common Stock stock for Q2 2023, up 2.4% quarter-over-quarter.
- 8 funds opened new Longevity Health Holdings, Inc. Common Stock positions in Q2 2023 and 13 closed out, a net change of -5 holders.
- The largest Longevity Health Holdings, Inc. Common Stock buyer in Q2 2023 was Aristeia Capital, an estimated $7.07M added.
- The largest Longevity Health Holdings, Inc. Common Stock seller in Q2 2023 was Balyasny Asset Management, an estimated $15.1M sold.
Based on aggregated 13F filings for Q2 2023.